-
A feast cooked up by UBC researchers has revealed singlet oxygen indoors for the first time.
-
When CEOs admit they have failed, stock analysts value their companies more highly: UBC study
Business leaders rarely want to take responsibility for unfavourable firm performance — but a new study from UBC Sauder shows that when they do, they can actually boost the value of their companies.
-
People who use alternative medicine favour risk and novelty, and distrust science
Over 40 per cent of Canadians have used at least one risk-associated alternative health-care treatment in the past 12 months, according to a new UBC study.
-
Does antimatter fall up or down? Physicists observe the first gravitational free-fall of antimatter
In the world’s first observation of the effect of gravity on antimatter, a group of researchers from Canada and around the world have made an important confirmation: like matter, antimatter does indeed ‘fall downwards’.
-
Depression, anxiety may be among early signs of MS
New research is painting a clearer picture of the early signs of multiple sclerosis (MS), showing that people are nearly twice as likely to experience mental illness in the years leading up to the onset of the diseases.
-
Student mental health and wellbeing a priority for UBC
Stress levels can rise with midterms, papers and assignments. For some students, that might mean increased mental health concerns.
-
Meet the adorable working animals of UBC: From fierce mousers to guiding paws
Charlie, Lola, Wilma and Daniel are among the many beloved “working” animals of UBC who make a paw-sitive impact on the university community.
-
New tool reveals inequitable distribution of ‘healing’ green spaces in Vancouver
Learn how restorative nature is distributed in Vancouver, as revealed by a new tool that evaluates spaces for qualities that promote mental well-being.
-
New variants, new vaccines. Here’s what you should know about COVID-19 going into fall.
Dr. Horacio Bach, a clinical assistant professor with UBC’s division of infectious diseases, answers key questions about the new COVID-19 variants and vaccines.